Leuprolide Recruiting Phase 2 Trials for High-risk Prostate Cancer / Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03541928Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
NCT03809000A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
NCT04249154Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
NCT02770391ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
NCT03899077Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP